Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Comment on: External Validation of the PREMISE Score in the Athens Stroke Registry.

Gattringer T, Posekany A, Kiechl S, Fazekas F, Enzinger C.

J Stroke Cerebrovasc Dis. 2019 Aug 20:104334. doi: 10.1016/j.jstrokecerebrovasdis.2019.104334. [Epub ahead of print] No abstract available.

PMID:
31444044
2.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
3.

Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.

Kneihsl M, Gattringer T, Bisping E, Scherr D, Raggam R, Mangge H, Enzinger C, Fandler-Höfler S, Eppinger S, Hermetter C, Bucnik B, Poltrum B, Niederkorn K, Fazekas F.

Stroke. 2019 Aug;50(8):2223-2226. doi: 10.1161/STROKEAHA.119.025339. Epub 2019 Jun 20.

PMID:
31216968
4.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 Sep;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. Epub 2019 May 22.

PMID:
31207467
5.

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Eppinger S, Gattringer T, Nachbaur L, Fandler S, Pirpamer L, Ropele S, Wardlaw J, Enzinger C, Fazekas F.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419835716. doi: 10.1177/1756286419835716. eCollection 2019.

6.

Real-life use of oral disease-modifying treatments in Austria.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

Acta Neurol Scand. 2019 Jul;140(1):32-39. doi: 10.1111/ane.13097. Epub 2019 Apr 22.

PMID:
30958901
7.

Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.

d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, Rocca MA.

Mult Scler. 2019 Mar 19:1352458519837707. doi: 10.1177/1352458519837707. [Epub ahead of print]

PMID:
30887862
8.

Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.

Marini S, Crawford K, Morotti A, Lee MJ, Pezzini A, Moomaw CJ, Flaherty ML, Montaner J, Roquer J, Jimenez-Conde J, Giralt-Steinhauer E, Elosua R, Cuadrado-Godia E, Soriano-Tarraga C, Slowik A, Jagiella JM, Pera J, Urbanik A, Pichler A, Hansen BM, McCauley JL, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Testai FD, Kittner SJ, Schmidt H, Enzinger C, Deary IJ, Rannikmae K, Samarasekera N, Salman RA, Sudlow CL, Klijn CJM, van Nieuwenhuizen KM, Fernandez-Cadenas I, Delgado P, Norrving B, Lindgren A, Goldstein JN, Viswanathan A, Greenberg SM, Falcone GJ, Biffi A, Langefeld CD, Woo D, Rosand J, Anderson CD; International Stroke Genetics Consortium.

JAMA Neurol. 2019 Apr 1;76(4):480-491. doi: 10.1001/jamaneurol.2018.4519.

9.

Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis.

Santangelo G, Altieri M, Enzinger C, Gallo A, Trojano L.

Neuropsychology. 2019 Mar;33(3):379-390. doi: 10.1037/neu0000520. Epub 2019 Jan 31.

PMID:
30702305
10.

Quantitative Susceptibility Mapping to Assess Cerebral Vascular Compliance.

Birkl C, Langkammer C, Sati P, Enzinger C, Fazekas F, Ropele S.

AJNR Am J Neuroradiol. 2019 Mar;40(3):460-463. doi: 10.3174/ajnr.A5933. Epub 2019 Jan 24.

11.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
12.

Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.

Chatterjee M, Koel-Simmelink MJ, Verberk IM, Killestein J, Vrenken H, Enzinger C, Ropele S, Fazekas F, Khalil M, Teunissen CE.

Mult Scler J Exp Transl Clin. 2018 Dec 24;4(4):2055217318819535. doi: 10.1177/2055217318819535. eCollection 2018 Oct-Dec.

13.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

14.

Predicting Early Mortality of Acute Ischemic Stroke.

Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, Haring HP, Ferrari J, Lang W, Willeit J, Kiechl S, Enzinger C, Fazekas F; Austrian Stroke Unit Registry Collaborators.

Stroke. 2019 Feb;50(2):349-356. doi: 10.1161/STROKEAHA.118.022863.

PMID:
30580732
15.

Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.

Pinter D, Enzinger C, Gattringer T, Eppinger S, Niederkorn K, Horner S, Fandler S, Kneihsl M, Krenn K, Bachmaier G, Fazekas F.

Eur J Neurol. 2019 May;26(5):727-732. doi: 10.1111/ene.13879. Epub 2019 Jan 9.

16.

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.

Mult Scler. 2018 Nov 22:1352458518810924. doi: 10.1177/1352458518810924. [Epub ahead of print]

PMID:
30463473
17.

Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature.

Gamperl I, Enzinger C, Pichler A, Feichtinger M, Schlager T, Fertl E.

Clin Case Rep. 2018 Sep 21;6(11):2121-2125. doi: 10.1002/ccr3.1816. eCollection 2018 Nov.

18.

Abnormal Blood Flow on Transcranial Duplex Sonography Predicts Poor Outcome After Stroke Thrombectomy.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Horner S, Thaler D, Kraner J, Fandler S, Colonna I, Fazekas F, Gattringer T.

Stroke. 2018 Nov;49(11):2780-2782. doi: 10.1161/STROKEAHA.118.023213.

PMID:
30355211
19.

The effect of disease modifying therapies on CD62L expression in multiple sclerosis.

Voortman MM, Greiner P, Moser D, Stradner MH, Graninger W, Moser A, Haditsch B, Enzinger C, Fuchs S, Fazekas F, Fessler J, Khalil M.

Mult Scler J Exp Transl Clin. 2018 Sep 20;4(3):2055217318800810. doi: 10.1177/2055217318800810. eCollection 2018 Jul-Sep.

20.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

21.

Cerebrovascular disorders.

Fazekas F, Gattringer T, Enzinger C.

Curr Opin Neurol. 2018 Aug;31(4):345-353. doi: 10.1097/WCO.0000000000000566. Review.

PMID:
29878907
22.

Teaching NeuroImages: Convexal subarachnoid hemorrhage accompanied by transient global amnesia.

Beitzke M, Enzinger C, Fazekas F.

Neurology. 2018 May 22;90(21):e1933-e1934. doi: 10.1212/WNL.0000000000005567. No abstract available.

PMID:
29784726
23.

Dysphagia in supratentorial recent small subcortical infarcts results from bilateral pyramidal tract damage.

Fandler S, Gattringer T, Pinter D, Pirpamer L, Borsodi F, Eppinger S, Niederkorn K, Enzinger C, Fazekas F.

Int J Stroke. 2018 Oct;13(8):815-819. doi: 10.1177/1747493018778141. Epub 2018 May 18.

PMID:
29775168
24.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

25.

Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors.

Pinter D, Gattringer T, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, Pichler A, Barro C, Eppinger S, Pirpamer L, Bachmaier G, Ropele S, Wardlaw JM, Kuhle J, Khalil M, Fazekas F.

J Cereb Blood Flow Metab. 2019 Sep;39(9):1669-1677. doi: 10.1177/0271678X18775215. Epub 2018 May 8.

PMID:
29737904
26.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
27.

Stroke Referrals from Nursing Homes: High Rate of Mimics and Late Presentation.

Kneihsl M, Enzinger C, Niederkorn K, Wünsch G, Müller L, Culea V, Lueger A, Fazekas F, Gattringer T.

Cerebrovasc Dis. 2018;45(3-4):109-114. doi: 10.1159/000487813. Epub 2018 Mar 14.

PMID:
29539602
28.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
29.

Grey-matter network disintegration as predictor of cognitive and motor function with aging.

Koini M, Duering M, Gesierich BG, Rombouts SARB, Ropele S, Wagner F, Enzinger C, Schmidt R.

Brain Struct Funct. 2018 Jun;223(5):2475-2487. doi: 10.1007/s00429-018-1642-0. Epub 2018 Mar 6.

30.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
31.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
32.

Predictors of gait speed and its change over three years in community-dwelling older people.

Pinter D, Ritchie SJ, Gattringer T, Bastin ME, Hernández MDCV, Corley J, Maniega SM, Pattie A, Dickie DA, Gow AJ, Starr JM, Deary IJ, Enzinger C, Fazekas F, Wardlaw J.

Aging (Albany NY). 2018 Jan 20;10(1):144-153. doi: 10.18632/aging.101365.

33.

Cognition in multiple sclerosis: State of the field and priorities for the future.

Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S.

Neurology. 2018 Feb 6;90(6):278-288. doi: 10.1212/WNL.0000000000004977. Epub 2018 Jan 17. Review.

34.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

35.

Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicates increased risk for intracranial hemorrhage.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Fischer R, Thaler D, Hermetter C, Wünsch G, Fazekas F, Gattringer T.

J Neurointerv Surg. 2018 Sep;10(9):882-887. doi: 10.1136/neurintsurg-2017-013617. Epub 2017 Dec 28.

PMID:
29288194
36.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
37.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
38.

Acute diffusion-weighted imaging lesions in cerebral amyloid angiopathy-related convexal subarachnoid hemorrhage.

Beitzke M, Enzinger C, Pichler A, Wünsch G, Fazekas F.

J Cereb Blood Flow Metab. 2018 Feb;38(2):225-229. doi: 10.1177/0271678X17744736. Epub 2017 Nov 23.

39.

Real-life clinical use of natalizumab and fingolimod in Austria.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T.

Acta Neurol Scand. 2018 Feb;137(2):181-187. doi: 10.1111/ane.12864. Epub 2017 Nov 20.

PMID:
29159801
40.

Serum neurofilament light is sensitive to active cerebral small vessel disease.

Gattringer T, Pinter D, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, Pichler A, Barro C, Gröbke S, Voortman M, Pirpamer L, Hofer E, Ropele S, Schmidt R, Kuhle J, Fazekas F, Khalil M.

Neurology. 2017 Nov 14;89(20):2108-2114. doi: 10.1212/WNL.0000000000004645. Epub 2017 Oct 18.

41.

The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.

Pichler A, Khalil M, Langkammer C, Pinter D, Ropele S, Fuchs S, Bachmaier G, Enzinger C, Fazekas F.

Mult Scler. 2019 Jan;25(1):48-54. doi: 10.1177/1352458517736149. Epub 2017 Oct 13.

PMID:
29027843
42.

Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke.

Phuah CL, Dave T, Malik R, Raffeld MR, Ayres AM, Goldstein JN, Viswanathan A, Greenberg SM, Jagiella JM, Hansen BM, Norrving B, Jimenez-Conde J, Roquer J, Pichler A, Enzinger C, Montaner J, Fernandez-Cadenas I, Lindgren A, Slowik A, Schmidt R, Biffi A, Rost N, Langefeld CD, Markus HS, Mitchell BD, Worrall BB, Kittner SJ, Woo D, Dichgans M, Rosand J, Anderson CD; METASTROKE; NINDS-SiGN Consortium; International Stroke Genetics Consortium.

Brain. 2017 Oct 1;140(10):2663-2672. doi: 10.1093/brain/awx220.

43.

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, Frisoni GB, Sastre-Garriga J, Rovira A, Enzinger C, Filippi M, Frederiksen J, Ciccarelli O, Kappos L, Barkhof F, Vrenken H; MAGNIMS study group and for neuGRID.

Neuroimage. 2017 Dec;163:106-114. doi: 10.1016/j.neuroimage.2017.09.011. Epub 2017 Sep 9.

PMID:
28899746
44.

Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.

Voortman MM, Pekar T, Bachmayer D, Archelos JJ, Stojakovic T, Scharnagl H, Ropele S, Pichler A, Enzinger C, Fuchs S, Fazekas F, Seifert-Held T, Khalil M.

Mult Scler J Exp Transl Clin. 2017 Aug 23;3(3):2055217317727294. doi: 10.1177/2055217317727294. eCollection 2017 Jul-Sep.

45.

FMRI to probe sex-related differences in brain function with multitasking.

Tschernegg M, Neuper C, Schmidt R, Wood G, Kronbichler M, Fazekas F, Enzinger C, Koini M.

PLoS One. 2017 Jul 31;12(7):e0181554. doi: 10.1371/journal.pone.0181554. eCollection 2017.

46.

Dolichoectasia and Small Vessel Disease in Young Patients With Transient Ischemic Attack and Stroke.

Thijs V, Grittner U, Fazekas F, McCabe DJH, Giese AK, Kessler C, Martus P, Norrving B, Ringelstein EB, Schmidt R, Tanislav C, Putaala J, Tatlisumak T, von Sarnowski B, Rolfs A, Enzinger C; Stroke in Fabry (SIFAP1) Investigators.

Stroke. 2017 Sep;48(9):2361-2367. doi: 10.1161/STROKEAHA.117.017406. Epub 2017 Jul 28.

PMID:
28754833
47.

Early Dysphagia Screening by Trained Nurses Reduces Pneumonia Rate in Stroke Patients: A Clinical Intervention Study.

Palli C, Fandler S, Doppelhofer K, Niederkorn K, Enzinger C, Vetta C, Trampusch E, Schmidt R, Fazekas F, Gattringer T.

Stroke. 2017 Sep;48(9):2583-2585. doi: 10.1161/STROKEAHA.117.018157. Epub 2017 Jul 17.

PMID:
28716980
48.

Mucosal biopsy shows immunologic changes of the colon in patients with early MS.

Moser AM, Spindelboeck W, Strohmaier H, Enzinger C, Gattringer T, Fuchs S, Fazekas F, Gorkiewicz G, Wurm P, Högenauer C, Khalil M.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e362. doi: 10.1212/NXI.0000000000000362. eCollection 2017 Jul.

49.

Assessment of ferritin content in multiple sclerosis brains using temperature-induced R*2 changes.

Birkl C, Carassiti D, Hussain F, Langkammer C, Enzinger C, Fazekas F, Schmierer K, Ropele S.

Magn Reson Med. 2018 Mar;79(3):1609-1615. doi: 10.1002/mrm.26780. Epub 2017 Jun 15.

PMID:
28618066
50.

Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis.

Borsodi F, Culea V, Langkammer C, Khalil M, Pirpamer L, Quasthoff S, Enzinger C, Schmidt R, Fazekas F, Ropele S.

PLoS One. 2017 Jun 2;12(6):e0178371. doi: 10.1371/journal.pone.0178371. eCollection 2017.

Supplemental Content

Loading ...
Support Center